ICH E9-compliant biostatistics services — from SAP development and randomization through final analysis reports and regulatory submissions.
Genelife Clinical Research boasts a Statistical Analysis department that excels in every aspect of statistical planning, execution, and reporting. With seasoned biostatisticians at the helm, Genelife ensures the robustness of clinical trial data for clients worldwide using our CRO in India.
Our biostatisticians are proficient in the principles of the International Council for Harmonisation (ICH) E9 guidelines. Statistical services encompass the full spectrum — from SAP inception to delivery of final analysis reports and regulatory submissions.
Genelife has devised a state-of-the-art computerized central randomization system — fully validated and compliant with 21 CFR Part 11 standards. This system guarantees rapid, secure 24/7 online access to randomization procedures for investigators globally.
ICH E9 Compliance: All statistical analyses at Genelife are conducted in accordance with ICH E9 guidelines, ensuring regulatory acceptability of statistical methodologies for global submissions by our CRO in India.